Skip to main content
Premium Trial:

Request an Annual Quote

Genome Compiler, DNA2.0 Partner on Synthetic Biology Software

NEW YORK (GenomeWeb) – Genome Compiler today announced a collaboration under which it will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.

"Direct connection to DNA2.0 services will simplify the design to order user experience, giving a more streamlined approach to the programming of living things," Omri Drory, CEO of Genome Compiler, said in a statement.

Genome Compiler, with offices in Los Altos, Calif. and Tel-Aviv, Israel, is a software developer creating computer-aided design and collaboration platforms for the synthetic biology industry.

Menlo Park, Calif.-based bioengineering firm DNA2.0 offers an integrated pipeline for designing, optimizing, and synthesizing genes and proteins.

In March, DNA2.0 licensed the technology underlying its Gene Designer software to Genome Compiler, ending a patent dispute between the two firms.

Financial and other terms of the deal were not disclosed.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.